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Available online 20 February 2008Shiga toxins (Stx), released into the intestinal lumen by enterohemorrhagic Escherichia coli (EHEC), are major
virulence factors responsible for gastrointestinal and systemic illnesses. These pathologies are believed to be
due to the action of the toxins on endothelial cells, which express the Stx receptor, the glycosphingolipid Gb3.
To reach the endothelial cells, Stx must translocate across the intestinal epithelial monolayer. This process is
poorly understood.We investigated Stx1movement across the intestinal epithelial T84 cell model and the role
of actin turnover in this transcytosis. We showed that changes in the actin cytoskeleton due to latrunculin B,
but not cytochalasin D or jasplakinolide, signiﬁcantly facilitate toxin transcytosis across T84 monolayers. This
trafﬁcking is transcellular and completely inhibited by tannic acid, a cell impermeable plasma membrane
ﬁxative. This indicates that actin turnover could play an important role in Stx1 transcellular transcytosis across
intestinal epithelium in vitro. Since EHEC attachment to epithelial cells causes an actin rearrangement, this
ﬁnding may be highly relevant to Stx-induced disease.
© 2008 Elsevier B.V. All rights reserved.Keywords:
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Latrunculin B1. Introduction
Shiga toxins 1 and 2 (Stx1, Stx2), are major virulence factors in
foodborne illnesses caused by enterohemorrhagic Escherichia coli
(EHEC). Stx1 and 2 belong to a class of so-called AB5 bacterial toxins
[1], which consist of a single catalytic A-subunit and a pentamer of
identical B-subunits, the latter responsible for receptor binding and
intracellular trafﬁcking. The A-subunit of Stx1 possessesN-glycosidase
activity and inhibits protein synthesis through speciﬁc removal of the
adenine base at position 4324 of the 28S ribosomal RNA of the 60S
subunit of the eukaryotic ribosome.
Individuals who become infected with EHEC often develop watery
diarrhea, which then becomes bloody, followed by recovery. How-
ever, up to 10% of infected individuals, mostly children, develop life-
threatening systemic complications including hemolytic uremic syn-
drome (HUS) [1,2]. Antibiotic use against the EHEC infections has
proven to be harmful, increasing the risks of HUS [3,4].
The principal gastrointestinal and systemic manifestations of Stx-
related diseases are believed to be due to the action of the toxins on
vascular endothelial cells, which express the glycosphingolipid Gb3,
the only well characterized Stx receptor [5,6]. EHEC strains are not
generally invasive like the prototypic Stx-producing Shigella dysenter-
iae type 1. The question of how Stx gains access from the gut lumen to, 720 Rutland Avenue, Johns
. Fax: +1 410 955 9677.
).
ll rights reserved.the underlying endothelial cells thus is crucial to understand the
systemic complications of EHEC.
Stx1 might traverse intestinal epithelial layer by transcellular or
paracellular pathways. It has been shown that Gb3 is absent from
human intestinal epithelial cells [7–11]. This excludes aGb3-dependent
route of toxin transcytosis and addsmore complexity to themechanism
of interaction between the toxin and intestinal epithelial cells.
Several studies have been performed to elucidate the pathways of
Stx transcytosis across intestinal epithelial cells. Translocation of Stx1
was examined [12,13] in highly polarized intestinal epithelial CaCo-2A
cells (Gb3 positive) and T84 cells (Gb3 negative). Biologically active
Stx1 was translocated from the apical to the basolateral surfaces of
both cell lines, which indicates that toxin transcytosis does not require
Gb3 receptor binding. Stx1 transcytosis did not affect either transe-
pithelial electrical resistance (TER) or movement of [3H]inulin, sug-
gesting that apical-to-basolateral toxin movement was through the
cells rather than the paracellular pathway [12,13]. The T84 cells have
been shown to be resistant to Stx1-induced cytotoxicity over 24 h of
exposure [9,12,13]. However, the efﬁciency of Stx1 transcytosis was
relatively low and only ~ 2% of the apical amount of Stx1 was trans-
ferred across the cell monolayer in 24 h.
We speculated that the process of transcellular toxin transcytosis
might be facilitated in EHEC infection. During the course of infection,
EHEC subvert the host cell signaling machinery to rearrange the actin
cytoskeleton and produce characteristic attaching and effacing lesions
on the surface of intestinal epithelial cells [14,15]. This actin rear-
rangement might facilitate the toxin movement across the monolayer.
Therefore, the goal of these studies was to determine the effect of actin
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intestinal epithelial barrier.
Here using an in vitro intestinal epithelial T84 cell model, we
demonstrated that latrunculin B (LatB), signiﬁcantly increases the
transcytosis of the Stx1 B-subunit (Stx1B). Complete inhibition of
LatB-induced Stx1B transcytosis by basolateral application of tannic acid
demonstrates that this toxin movement occurs through the cells, rather
than through tight junctions (TJ). The effect of LatB on Stx1 transcytosis
is speciﬁc, and neither cytochalasin D (CytD) nor jasplakinolide (Jasp),
which both affect ﬁlamentous actin turnover and similarly to LatB
decrease TERof intestinal epithelialmonolayers, did not inﬂuence Stx1B
transport across the T84 cells. This LatB-facilitated Stx1B transcellular
transcytosis is associated with changes in amount of at least one actin-
binding protein, such as phospho-coﬁlin-1. We suggest that changes in
actin cytoskeleton similar to these caused by LatB might occur during
EHEC interaction with the intestinal epithelium.
2. Materials and methods
2.1. Materials
Puriﬁed Stx1 and recombinant Stx1B were prepared by Dr. A. Kane (GRASP Center,
Tufts New England Medical Center, Boston, MA) as previously described [16,17]. The
quality of Stx1 and Stx1B has been checked on 15% SDS-PAGE followed by GelCode Blue
staining (Pierce, Rockford, IL) and two bands (~ 32 kDa for A-subunit and) or one band
(b 10 kDa for B-subunit) respectively, were detected. B-subunit of Cholera toxin (CTB)
was from List Biological Laboratories, Inc. LatB was from Axxora (San Diego, CA). The
following antibodies were rabbit polyclonals: anti-coﬁlin, a generous gift from Dr. J.R.
Bamburg (Colorado State University, CO), anti-phospho-coﬁlin and anti-proﬁlin from
Cell Signaling Technology (Danvers, MA). Rabbit monoclonal anti-GAPDH was from US
Biological (Swampscott, MA), mouse monoclonal anti-cathepsin D was a gift from Dr. A.
Hubbard (Johns Hopkins University, Baltimore, MD). All ﬂuorescent secondary anti-
bodies, phalloidin, and 40 kDa dextran conjugated to Alexa 488 ﬂuorescent dye were
from Molecular Probes-Invitrogen (Carslbad, CA). Stx1, CTB, and recombinant Stx1B
were conjugated with Alexa ﬂuor 680, Alexa ﬂuor 568, or Alexa ﬂuor 488 reactive dyes
according to the manufacturer's protocol (Molecular Probes—Invitrogen). All other
chemical reagents were purchased from Sigma (St. Louis, MO).
2.2. Cell culture
Human colonic epithelial T84 cells (A.T.C.C., Manassas, VA) were grown and
maintained in culture in DMEM (Dulbecco's modiﬁed Eagle's medium)/Ham's F-12
medium (1:1) supplemented with 10% fetal bovine serum, 100 U/ml penicillin and
100 μg/ml streptomycin. All media ingredientswere obtained from Invitrogen (Carlsbad,
CA). Monolayers (passage 27–45) were grown on polycarbonate inserts with 0.4-μm
pore size (Costar, Cambridge, MA) for 7–12 days. The experiments were performed on
conﬂuent monolayers with transepithelial electrical resistance (TER) ~ 1500 Ω·cm2.
2.3. Detection of Stx1, Stx1B, CTB and dextran transcytosis
Cells grown on polycarbonate inserts were incubatedwith indicated concentrations
of Stx1, Stx1B, CTB or dextran in the presence or absence of LatB over the indicated
times. At the end of incubation, the inserts were removed and the relative ﬂuorescence
intensity in the lower chamber was measured by Odyssey Fluorescence Imaging System
(Li-Cor Biosciences, Lincoln, NE).
2.4. Detection of Intracellular Stx1B
Conﬂuent T84 cells were incubated over indicated timewith indicated concentrations
of Stx1B conjugated to Alexa 680 ﬂuorescent dye (Stx1B-680). Cells then were washed
three timeswith cold PBS to remove extracellular toxin and lysed in RIPA buffer (1% Triton
X-100, 0.5% deoxycholic acid, 0.1% SDS, 50mMTRIS HCL, pH 7.4,150mMNaCl), containing
0.5 mM Na3VO4 and Protease inhibitor cocktail 1:1000 (Sigma P8340) and sonicated.
Lysates were centrifuged at 20,000 ×g at 4 °C for 15 min. Equal amounts of collected
proteins were loaded into the 96-well plates and the ﬂuorescence intensity of Stx1B-680,
which corresponds to the amount of intracellular Stx1B, wasmeasured and normalized by
the autoﬂuorescence of an equal amount of protein from cells not exposed to Stx1B.
For experiments with Brefeldin A (BFA), T84 cells were pretreated with 0.1 µM BFA
for 1 h and incubated with Stx1B in the presence of BFA for additional 1, 4 or 24 h. The
amount of Stx1B inside the BFA-treated cells and in lower chambers relative to these in
controls was measured by Odyssey.
2.5. Immunoblotting
Equal amounts of collected proteins from total cell lysates were separated by SDS-
PAGE, transblotted onto nitrocellulose membranes, and analyzed by Western blot.Proteins of interest were detected by either ECL Western Blotting Detection reagents
(Amersham, Princeton, NJ) or by Odyssey Fluorescence Imaging System.
2.6. Immunoﬂuorescence
For F-actin detection, the conﬂuent T84 monolayers were incubated over indicated
times with 0.5 µg/ml Stx1B conjugated to Alexa 568 ﬂuorescent dye (Stx1B-568), ﬁxed
with 3% formaldehyde in PBS for 10min.,washed extensively in PBS, non-permeabilized or
permeabilized with 0.1% saponin, blocked with 2% BSA and 15% FBS for 30 min. and
incubated 1 h with phalloidin and Hoechst for nuclear staining. For Stx1B and CTB co-
localization experiments, cells were incubated over the indicated time with 0.5 µg/ml
Stx1B-568 and 0.5 µg/ml CTB conjugated to Alexa ﬂuor 488 (CTB-488) and ﬁxed as above.
For Stx1B and lysosomal co-localization, cells were incubated over the indicated timewith
0.5 µg/ml Stx1B-568, ﬁxed, permeabilized and blocked as above, incubated with anti-
cathepsin D antibody at room temperature for 1 h, washed 3 times in PBS and incubated
with secondary ﬂuorescent antibodies for an additional 1 h. All cell preparations were
mounted on glass slides for confocal microscopy examination. Fluorescent image
acquisition of tissue was performed using a Zeiss 410 LSM confocal imaging system.
Collected 8-bit ﬂuorescence images of confocal optical sectioning with 0.5 µm steps were
stored on disc and ﬂuorescence intensity was quantiﬁed by MetaMorph software
(Molecular Devices Corporation, Downingtown, PA), as we previously described [18].
2.7. Quantiﬁcation of G-actin and F-actin
Fractionation of G-actin and F-actin was performed by Triton X-100 extraction of
intracellular actin as described [19]. Brieﬂy, T84 cells were washed with HBSS and G-
actinwas extracted by gentle shaking for 5min at room temperature in HBSS containing
1% Triton X-100, proteinase inhibitor cocktail and 1 µg/ml phalloidin to prevent ﬁlament
disassembly. The Triton X-100-soluble G-actin fractionwasmixedwith an equal volume
of 2× SDS sample buffer and boiled. Cells were then brieﬂy washed with HBSS and the
Triton X-100-insoluble F-actin fractionwas collected by scraping cells in two volumes of
SDS sample buffer, and boiled. The amount of actin in each fraction was determined by
gel electrophoresis, Western blotting, and Odyssey Fluorescence Imaging System as
described above.
2.8. Statistical analysis
Values are presented as mean±SEM. Normal distribution for each dataset was
tested using statistical package available at http://home.ubalt.edu/ntsbarsh/. Statistical
signiﬁcance was determined using Student's unpaired t-test and p-value b 0.05 was
considered signiﬁcant.
3. Results
3.1. Stx1 and Stx1B are both transcytosed across T84 cells
It has been previously shown that ~ 2% of apically added active Stx1
holotoxin translocates across the T84 monolayer in 24 h [12]. We
repeated these experiments using both ﬂuorescently labeled holoto-
xin (Stx1-680) and B-subunit of Stx1 (Stx1B-680). Conﬂuent T84 cells
were exposed apically either to Stx1B-680 (0.1 µg), or to increasing
amount of Stx1B-680 (0.06 µg, 0.125 µg, 0.25 µg and 0.5 µg) in 0.5ml of
apical media. The relative amount of transcytosed Stx1-680 or Stx1B-
680 was measured in the lower chamber media 24 h later by
quantifying the toxin 680 nm relative ﬂuorescence intensity. The
absolute amount of transcytosed Stx1-680 or Stx1B-680 was calcu-
lated from ﬂuorescence intensity by comparison to the Stx1-680 or
Stx1B-680 ﬂuorescence intensity calibration curve generated from
three different concentrations of Stx1-680 or seven different concen-
trations of Stx1B in a range between 1 µg/ml and 5 ng/ml. Similarly to
the non-ﬂuorescent holotoxin [12], Stx1-680 and Stx1B-680 transcy-
tosis across conﬂuent T84 cells is a slow process. Only ~ 4 ng of Stx1-
680, which corresponds to 3.9±0.6% of total apical Stx1-680 (n = 6
ﬁlters) was transcytosed across themonolayer in 24 h. In case of Stx1B,
only ~ 4 ng, ~ 8 ng, ~ 13 ng and ~ 28 ng of toxin respectively was
recovered from lower chamber in 24 h, which corresponds to 6.0%±0.4
of total apical amount of toxin (n = 6 ﬁlters per each conditions).
We also measured the TER of T84 monolayers treated for 24 h
with Stx1B-680 to ensure that there were no Stx1B-induced changes
in the TJ. Similarly to the previously studied holotoxin [9,12,13]
neither 1 µg/ml of apical non-ﬂuorescent Stx1B nor Stx1B-680
change TER over 24 h of incubation. From these experiments we
concluded that Stx1B is sufﬁcient for holotoxin transcytosis across
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Stx1 translocation across the intestinal epithelial monolayer.
As in case of holotoxin [12], Stx1B-680 transcytosis in T84 cells was
also insensitive to 0.1 µM BFA, indicating a lack of involvement of the
retrograde pathway in toxin transcytosis. Higher doses of BFA were
toxic to the T84 cells, caused a signiﬁcant drop in TER and apoptosis
characterized by caspase-3 activation (data not shown).
3.2. Stx1 and Stx1B are internalized by Gb3 free intestinal epithelial T84
cells
Stx1 movement through the Gb3-negative T84 monolayers
without changes in TER or paracellular permeability [9,12] suggestsFig. 1. Stx1B uptake by T84 cells is not receptor-mediated, but is an actin-dependent process
A— three apical concentrations of Stx1-680 (0.05, 0.1 and 0.2 µg/ml) and Stx1B (0.3, 0.5 and
(black squares) or Stx1 at 24 h (open circles) were measured in total cell lysates. B — Two
applied to the apical surface of T84 cells. Stx1B amount in 100 µg of protein from total cell l
incubation. C–F — representative confocal images of T84 cells incubated with Stx1B-568 (re
confocal microscopy XZ projections, respectively. Nuclei in all panels — blue (by Hoechst). W
positive vesicles were present inside the cells in 24 h than in 4 h. The majority of Stx1B and
does not co-localize with B-subunit of cholera toxin. G— representative confocal image of Stx
J–L — Stx1B intacellular pattern partially overlaps with cathepsin D. J — representative confothat in the absence of Gb3 the Stx1 is endocytosed by a yet
uncharacterized mechanism. We hypothesized, if Stx1/Stx1B uptake
by Gb3-free cells is a receptor mediated process (possibly another
low afﬁnity or low expression receptor), then ﬁrst order reaction
kinetics should apply, which predicts a concentration and time-
dependent saturated uptake due to receptor saturation [20]. To
determine the toxin uptake as a function of the apical toxin con-
centration and as a function of time, T84 cells were incubated with
Stx1-680 holotoxin or Stx1B-680 and the Stx1-680 or Stx1B-680
ﬂuorescence intensity in total cell lysates, which corresponds to the
relative amount of endocytosed toxin, was measured. Both, dose
and time dependencies of toxin uptake demonstrated a linear non-
saturating relationship between the amounts of endocytosed. A and B — concentration and time dependencies of Stx1 and Stx1B uptake by T84 cells.
1 µg/ml) were used and the intracellular amount of Stx1B at 6 h (open squares) and 24 h
concentrations of Stx1B (0.5 µg/ml — open squares and 1 µg/ml — black squares) were
ysates was measured as ﬂuorescence intensity of Stx1B-680 at 15 min, 3, 6 and 24, h of
d) and 40 kDa dextran-488 (green) for C — 4 h and E — 24 h. D and F are corresponding
hite lines in C and E show the direction of optical z-sections. More Stx1B and dextran-
dextran vesicles were co-localized (yellow) at 4 h and 24 h of incubation. G–I — Stx1B
1B-568, and H— corresponding image of B-subunit of cholera toxin-488, and I— overlay.
cal image of Stx1B-568, and K — corresponding image of cathepsin D, and L — overlay.
Fig. 3. LatB signiﬁcantly increase Stx1 transcellular transcytosis across T-84monolayers.
Stx1B-680 relative ﬂuorescence intensity in A— total cell lysates from cells 1— contols;
or treatedwith 2— 1 µM LatB; 3— 1 µMCytD; 4— 1 µM Jasp. LatB signiﬁcantly increased
the intracellular Stx1B amount compared to control non-treated cells, while CytD
signiﬁcantly decreased it (⁎pb0.05 vs. control). Jasp did not affect the intracellular Stx1B
content. Stx1B-680 relative ﬂuorescence intensity in B — lower chamber (transcytosis)
with C — representative images of Stx1B-680 ﬂuorescence intensity in lower chamber.
LatB signiﬁcantly increased (⁎pb0.05 vs. control) the Stx1B transcytosis, while neither
CytD nor Jasp affected the Stx1B transcytosis. The data shown are means±SEM for six
independent experiments.
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respectively (Fig. 1A and B). Additionally, incubation of T84 cells at
4 °C with ﬂuorescently labeled Stx1B over 3 h did not result
in detectable toxin binding to the apical surface (data not shown).
These results demonstrate that Stx1 and Stx1B uptake by T84 cells
is not a receptor mediated process.
To further test the hypothesis that Stx1/Stx1B uptake into T84
cells is mainly through non-receptor mediated endocytosis, T84
cells were incubated simultaneously with ﬂuorescently labeled
Stx1B and 40 kDa dextran, the latter being a ﬂuid phase endocytosis
marker, the MW of which closely matches the MW of the Stx1B
pentamer. The distribution of Stx1B relative to the dextran was
compared by confocal microscopy after 4 and 24 h of co-incubation
(Fig. 1C–F). The co-localization function (MetaMorph), showed that
~78±13% of Stx1B intracellular vesicles were co-localized with
40 kDa dextran vesicles upon 24 h of co-incubation. This suggests
that ﬂuid phase endocytosis may be a major pathway for Stx1
uptake in receptor-free cells. The Stx1B co-localized signiﬁcantly
neither with B-subunit of cholera toxin (CTB) (Fig. 1G–I), which
upon uptake by GM1-receptor mediated endocytosis marks the
whole retrograde pathway [21], nor with a marker for recycling
endosomes, Rab11 (data not shown). However, the Stx1B intracel-
lular pattern partially matched the pattern of the lysosomal marker
cathepsin D (Fig. 1J–L).
3.3. Cortical actin is involved in Stx1/Stx1B uptake by T84 cells
Fluid phase endocytosis is an actin-driven process and in polarized
cells the cargo resides inside apical actin-coated vesicles [22–24]. We
found that during uptake, Stx1B resides inside spherical actin vesicles
on the apical surface of T84 cells (Fig. 2A–F). Moreover, Stx1B uptake is
accompanied by an increase in apical F-actin amount. However, inside
the cells the Stx1B vesicles are not covered by actin (Fig. 2G), indi-
cating that Stx1B-containing vesicles undergo some sub-apical
sorting. We concluded that in receptor-free intestinal epithelial cells,
actin remodeling is involved in Stx1/Stx1B uptake into some sub-
apical compartment.
3.4. LatB signiﬁcantly increased the transcytosis and uptake of Stx1B
Based on our data, we hypothesized that changes in actin cyto-
skeletonmight facilitate toxinmovement across the intestinal epithelial
layer. Subsequently, the effect of actin polymerizing-depolymerizing
agents, including CytD, LatB and Jasp, on Stx1/Stx1B uptake and
transcytosis was studied. For these experiments, T84 cells were treatedFig. 2. A— representative confocal image of the apical area of T84 cellswhich are in the process of Stx1B uptake, Stx1B-568 (red), actin (by phalloidin-Alexa 488) (green). B, C andD— zoom
on Stx1B-actin vesicle (square fromA). Note, that Stx1B (red) is coated by the F-actin (green) sphere (arrows). E and F— XZ projection through non-permeabilized T84 cells incubatedwith
Stx1B for 4h.Apical actin (green) formsa sphere aroundStx1Bvesicle (red),which is takenupacross theapicalmembrane. SomeStx1Bvesicles are already inside thecells.G—XZprojection
through permeabilized T84 cells. Stx1B vesicles (red) inside the cells are not covered by actin (green), indicating that upon internalization the Stx1B vesicles are loosing F-actin coating.
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the last 4 h or 1 µM of CytD for the last 2 h. These treatments had been
previously reported to signiﬁcantly affect the F-actin pool in T84 cells
[22,25].
Quantiﬁcation of Stx1B in total cell lysates (Fig. 3A) showed sig-
niﬁcant increase in the amount of intracellular toxin due to LatB. CytD
signiﬁcantly decreased the intracellular amount of Stx1B, while Jasp
had no effect on the amount of intracellular toxin. Quantiﬁcation of
Stx1B in the lower chamber showed that LatB signiﬁcantly increased
toxin transcytosis, while neither CytD nor Jasp affected transcytosis
(Fig. 3B and C).
These data show that LatB treatment possibly increases both the
toxin uptake across the apical membrane and toxin efﬂux through
the basolateral membrane. To test whether actin modiﬁcation by
LatB stimulates both processes, the effect of LatB on Stx1B uptake
and transcytosis was measured over shorter periods of time than
24 h. For these experiments T84 cells were exposed simultaneously
to 1 µg/ml Stx1B-680 and 1 µM LatB over different times between
15 min and 4 h, and the amounts of toxin inside the cells and in the
lower chamber were compared to control cells incubated with Stx1B
only (Fig. 4A and B). Incubation with LatB over 30 min signiﬁcantly
increased the amount of intracellular toxin compared to control
cells; 4 h of LatB treatment increased the intracellular amount of
Stx1B ~ 5 times. LatB also signiﬁcantly increased Stx1B transcytosis,
indicating that in T84 cells LatB facilitates the Stx1B transport across
both apical and basolateral membranes. However, there was a time
delay in LatB stimulated Stx1B transcytosis compared to its effect on
Stx1B uptake, and at times shorter than 1 h, LatB treatment did not
affect transcytosis (Fig. 4B). Treatment of T84 cells with different
concentrations of LatB over 4 h showed signiﬁcant increase of Stx1B
transcytosis starting at 0.5 µM LatB (Fig. 4C).
It is well established that latrunculins, including LatB, signiﬁ-
cantly decrease the TER of polarized intestinal epithelial monolayers,
including T84 cells [19,26,27]. To ensure that LatB induced increase
in Stx1 transcytosis was not caused by changes in TER (Fig. 4 B and C)
and possibly changes in paracellular permeability [24,25], but is due
to the actin-dependent changes in toxin uptake and transcellular
trafﬁcking, T84 cells were treated basolaterally for 4 h with 0.1%
tannic acid, a cell-impermeable cross-linker of cell surface carbohy-
drates that selectively ﬁxes the plasma membrane but does not dif-Fig. 4. LatB time and dose effects on Stx1B uptake and transcytosis. A — Stx1B-680 relative
(black circles) and non-treated (open squares) cells. LatB signiﬁcantly increased Stx1B uptak
intensity of transcytosed Stx1B-680 (left) as a function of time from 1 µM LatB treated (black
after application (⁎pb0.05 vs. control). While TER of T84monolayers (right) dropped signiﬁca
triangles). C — Relative ﬂuorescence intensity of transcytosed Stx1B-680 (left) as a function o
rhombs) measured after 4 h of treatment. Starting from 0.5 µM LatB signiﬁcantly increas
transcytosis induced by LatB. TER (right) signiﬁcantly decreased from 0.25 µM LatB (⁎⁎pb0fuse across the TJ [22,28–30]. This treatment did not change the
properties of the TJ in T84 monolayers [22]. Tannic acid completely
inhibited the effect of LatB on Stx1B transcytosis (Fig. 4C), sug-
gesting that LatB facilitated transcytosis of Stx1B is a trans-
cellular process and actin polymerization–depolymerization plays
an important role in its regulation. Basolateral tannic acid treat-
ment in the presence of LatB also signiﬁcantly increased the Stx1B
amount in total cell lysates compared to non-treated controls. Thus,
relative ﬂuorescence intensity in control cells exposed to Stx1B-680
for 4 h was 57±11 U, while in cells treated with for 4 h with 1 µM
LatB apically and tannic acid basolaterally the Stx1B-680 relative
intensity was 678±37 units (p b 0.05 vs. control, 3 independent ex-
periments). Tannic acid alone did not affect the amount of intra-
cellular toxin compared to the control cells, and Stx1B-680 relative
intensity in the presence of tannic acid was 66±8 U (3 independent
experiments).
The LatB-mediated changes in cytoskeleton that facilitate Stx1B
uptake and transcytosis through T84 monolayers are different from
these leading todecrease inTER (Fig. 3),which occur rapidly 10–15min
after treatment and at low LatB concentrations that do not affect Stx1B
transcytosis [27].
3.5. LatB facilitates the transcytosis of other molecules across intestinal
epithelial cells
The effect of LatB on transcellular transcytosis has not been studied
in detail in polarized intestinal epithelial cells. Subsequently, we
tested whether LatB stimulates the transcytosis of several molecules
which use different endocytic mechanisms for uptake. For these
experiments, T84 cells were incubated for 4 h in the presence or the
absence of 1 µM LatB either with 40 kDa dextran or CTB, the last binds
to apical GM1 receptors. CTB can be taken up by clathrin- and caveolin-
dependent and independent mechanisms and is transcytosed inde-
pendently of its retrograde trafﬁcking pathway [21,31,32]. Similarly to
Stx1B, LatB increased dextran transcytosis from 19.5±4.2 relative
ﬂuorescent intensity units in control cells to 182.7±3.7 in the presence
of LatB (p b 0.05; n = 8 experiments). LatB also signiﬁcantly increased
the transcytosis of CTB from 30.2±2.8 relative ﬂuorescent intensity
units in control cells to 664.8±111.0 in the presence of LatB (p b 0.05;
n=8 experiments).intensity ﬂuorescence in total cell lysates as a function of time from 1 µM LatB treated
e in 30 min after its apical application (⁎pb0.05 vs. control). B — Relative ﬂuorescence
squares) and non-treated (open) cells. LatB signiﬁcantly increased Stx1B transcytosis 1 h
ntly in 30min of LatB treatment (black triangles) compared to control monolayers (open
f LatB concentration (open squares) or LatB in combination with 0.1% tannic acid (open
ed Stx1B transcytosis (⁎pb0.05 vs. control). Tannic acid completely prevented Stx1B
.05 vs. control). The data shown are means±SEM for four independent experiments.
Fig. 5. Effect of LatB on expression of actin and actin-binding proteins. A — Representative immunoblot from cells incubated with 1 µM LatB for 4 h and control non-treated cells.
B— Quantitative analysis of coﬁlin-1 (striped bars), phosphocoﬁlin-1 (black bars) and proﬁlin (white bars) expression normalized on GAPDH in the absence and the presence of 1 µM
LatB for 4 h. LatB signiﬁcantly increase the amount of phosphocoﬁlin-1 (⁎pb0.05 vs. control). The data shown are means±SEM for three independent experiments. C— LatB-induced
changes in the relative amount of G-actin alone (open squares) or in the G/F actin ratio (black squares) are closely followed by the increase in phosphocoﬁlin-1 (black triangles). The
amount of G actin, and G/F-actin ratio and the amount of phosphocoﬁlin-1 normalized on GAPDH are signiﬁcantly higher at each timepoint of LatB treatment compared to time=0
without LatB (pb0.05).
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Stx1B facilitated transcytosis
Additionally to the sequestration of monomeric G-actin, both Lat A
and B has been shown to inﬂuence the expression or phosphorylation
of several actin binding proteins [33,34]. We tested whether LatB-
induced increase in G-actin is also accompanied by changes in the
expression or postranslational modiﬁcation of some G-actin-binding
proteins in T84 cells, such as coﬁlin and proﬁlin [35,36]. For these
experiments, cells were treated with 1 µM LatB over different time
intervals between 15 min and 4 h, and the expression of coﬁlin-1 and
its phosphorylated form, and proﬁlin, were tested in total cell lysates
by immunoblotting. LatB treatment signiﬁcantly increased the coﬁlin-
1 phosphorylation, which occurred as early as 15 min and continued
over 4 h (Fig. 5). Moreover, the increase in the amount of phospho-
coﬁlin-1 over time of LatB treatment correlates (r = 0.93 by correlation
test for independent variables from Excel) with increase in the
amount of G-actin, reﬂected in G/F actin ratio (Fig. 5C). Neither the
total amount of coﬁlin-1 nor proﬁlin changed over these experimental
time intervals (Fig. 5). Additionally, the total amount of other actin-
binding proteins such as ezrin and vinculin did not change upon LatB
treatment (data not shown). These data suggest that facilitation of
transcellular transcytosis by LatB may be related to LatB-induced
changes in the activity of coﬁlin-1.
4. Discussion
The Stx translocation across the intestinal epithelial layer to spread
systemically is a necessary step in the development of the EHEC-
induced spectrum of disease. However, the mechanisms of this trans-
location are unknown. The ability of fully active Stx1 and Stx2 to cross
the epithelial barrier through the cells has been demonstrated
[12,13,37–39]. However, the efﬁciency of transcytosis was very low
with only ~ 2% of apical Stx1 crossing monolayers in 24 h. Although
such a small amount of toxin potentially could be responsible for
systemic complications, we speculated that the changes in host cell
protein expression and particularly, in actin and actin-binding proteins
due to EHEC attachment and effacement [14,15] might stimulate toxin
uptake and transcytosis. The impact of EHEC infection on the host
proteins has not been investigated in detail. However, there are some
evidences that EHEC colonization changes the protein expression in
intestinal epithelial cells [40]. Moreover, proteomic analysis of intes-
tinal epithelial Caco-2 cells infected with enteropathogenic E. coli(EPEC), which form attaching/effacing lesions similar to those of EHEC,
showed signiﬁcant increase in the abundance of multiple actin de-
polymerizing proteins [41]. For instance, actin severing proteins
gelsolin and coﬁlin were upregulated 3.57 and 2.5 times, respectively.
This shows that changes in actin binding proteins occur as a part of
bacterial attachment and effacement to the intestinal epithelial cells.
Here we demonstrate that actin depolymerizing drug LatB
signiﬁcantly increases Stx1B transcytosis in a time and a concentra-
tion-dependent manner. It is known that LatB decreases TER and
increases permeability to ions and uncharged molecules with size
b 10 kDa [22,27]. We show that the LatB facilitated Stx1B transcytosis
is not across the TJ, because Stx1B transcytosis in the presence of LatB
is completely blocked by basolateral application of tannic acid. Re-
cently the addition of tannic acid to the basolatheral cell surface has
been shown to inhibit the apical to basolateral transcellular transcy-
tosis of adeno-associated virus [39]. The selectivity of tannic acid
(apical vs. basolateral) has been previously tested in T84 cells [22], and
apically (but not basolaterally) applied tannic acid completely
prevented cholera toxin apical uptake. In contrast, basolateral tannic
acid (but not apical) effectively inhibited uptake of transferrin from
the basolateral side. Taken together, our data show that LatB facilitates
Stx1B transepithelial ﬂux is transcellular and not paracellular.
Additionally, both CytD and Jasp treatments have also been shown
to decrease TER of intestinal epithelial monolayers [26,42,43]. How-
ever, neither drug increased Stx1B transcytosis in T84 cells, supporting
our conclusion that LatB facilitates transcellular transcytosis of toxin.
The increase in Stx1B amount in total cell lysates due to the tannic acid
treatment in the presence of LatB additionally supports that the toxin
moves across the cells.
It has been shown that CytD inhibits both receptor mediated and
ﬂuid phase endocytosis at the apical surface [44–46], while Jasp
stimulates basolateral ﬂuid phase endocytosis, but does not affect
apical uptake [43]. These data are in good agreements with our
ﬁndings that CytD inhibits Stx1B apical uptake, and Jasp does not
change it. In general, latrunculins signiﬁcantly inhibit receptor me-
diated endocytosis [44,47]. However, latrunculins have been shown to
stimulate internalization of α-amino-3-hydroxy-5-methyl-4-isoxazo-
lepropionic acid (AMPA) receptors and the cystic ﬁbrosis transmem-
brane conductance regulator (CFTR), while the mechanisms of
endocytosis have not be addressed [48,49]. The increase in apical
Stx1B uptake by LatB (but not by CytD or Jasp) serves as additional
evidence that Gb3-free T84 cells take up Stx1B by a non-receptor
mediated pathway.
376 I. Maluykova et al. / Biochimica et Biophysica Acta 1782 (2008) 370–377These results prompted us to look for the LatB induced molecular
changes which might be involved in the regulation of transcellular
transcytosis. LatB affects the kinetics of actin polymerization by
forming 1:1 molar complexes with G-actin [50,51]. The actin seques-
tration over time leads to changes in activity and expression of several
actin binding proteins, including vinculin, VASP, proﬁlin, coﬁlin and
ADF [33,34]. The novelty in our experiments is that LatB rapidly
(15 min) increased the amount of phosphorylated coﬁlin-1, which is
inactive in terms of actin binding [52], while the total amount of this
protein was unchanged. This effect was sustained over the 4 h of
experimental time. Coﬁlin-1 is a ubiquitous mediator of actin ﬁlament
turnover in eukaryotes. In the phosphorylated form coﬁlin is unable to
bind to actin, while the dephosphorylation of coﬁlin enables its actin
severing and depolymerizing activity [33,52]. LatB-induced coﬁlin-1
phosphorylation should lead to F-actin destabilization and this might
be important for stimulation of the transcellular pathway. A possibility
that LatB inﬂuences the expression of other proteins involved in actin
turnover in intestinal epithelial cells remains to be tested.
Interestingly, this LatB mediated route for transcytosis might be a
common pathway for many molecules which are able to trafﬁc across
epithelial monolayers. It has been previously shown that cholera toxin
(CT) and its B-subunit are transcytosed transcellularly by T84 cells, and
BFA did not inhibit, but rather stimulated this process [31]. Moreover,
CT transcytosis directly correlated with CT-induced Cl-secretion, indi-
cating functional importance of this pathway. The results allow us to
speculate that interaction of bacteria or bacterial products with
intestinal epithelial cells might potentially recreate the LatB-induced
molecular changes which signiﬁcantly facilitate the transcellular
transcytosis of toxins and other antigens. These data that two different
AB5 toxins [53]move across the intestinal epithelial cells by a Golgi/ER
independent pathway shows the importance of transcellular transcy-
tosis in the interactions of intestinal epithelial cells with a broad
variety of bacterial products, which similarly to Stx might gain access
to the underlying tissues.
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